Nuvo Pharmaceuticals Inc., a commercial healthcare company, produces and sells pharmaceutical products in the United States, Canada, and Europe. It offers Pennsaid, a topical pain product that is used to treat the signs and symptoms of osteoarthritis of the knee; Pennsaid 2%, a follow-on product to Pennsaid for the treatment of the pain of osteoarthritis of the knee; Heated Lidocaine/Tetracaine (HLT) Patch, a topical patch that provides local analgesia prior to painful needle procedures, such as dialysis, blood draws, and pediatric needles; and Resultz, an over-the-counter product intended to kill head lice and remove their eggs from hair. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone905-673-6980
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$15.43 million
Profitability
Miscellaneous
Employees97
Next Earnings Date11/14/2019 (Estimated)
OptionableNot Optionable
Nuvo Pharmaceuticals (OTCMKTS:NRIFF) Frequently Asked Questions
What is Nuvo Pharmaceuticals' stock symbol?
Nuvo Pharmaceuticals trades on the OTCMKTS under the ticker symbol "NRIFF."
How were Nuvo Pharmaceuticals' earnings last quarter?
Nuvo Pharmaceuticals Inc (OTCMKTS:NRIFF) issued its earnings results on Wednesday, August, 14th. The company reported ($0.54) earnings per share (EPS) for the quarter. The business had revenue of $12.40 million for the quarter. Nuvo Pharmaceuticals had a negative net margin of 19.00% and a negative return on equity of 43.32%. View Nuvo Pharmaceuticals' Earnings History.
When is Nuvo Pharmaceuticals' next earnings date?
Has Nuvo Pharmaceuticals been receiving favorable news coverage?
News headlines about NRIFF stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Nuvo Pharmaceuticals earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Nuvo Pharmaceuticals.
Who are some of Nuvo Pharmaceuticals' key competitors?
Some companies that are related to Nuvo Pharmaceuticals include OncoSec Medical (ONCS), Tetraphase Pharmaceuticals (TTPH), Mateon Therapeutics (MATN), ANCHIANO THERAP/S (ANCN), Heat Biologics (HTBX), RegeneRx Biopharmaceuticals (RGRX), Prana Biotechnology (PRAN), Soligenix (SNGX), Fibrocell Science (FCSC), Pulmatrix (PULM), Amarillo Biosciences (AMAR), Regulus Therapeutics (RGLS), Adial Pharmaceuticals (ADIL), Kazia Therapeutics (KZIA) and Oncolytics Biotech (ONCY).
Who are Nuvo Pharmaceuticals' key executives?
Nuvo Pharmaceuticals' management team includes the folowing people:
- Mr. Robert Paul Harris, Exec. Chairman (Age 64)
- Mr. Jesse F. Ledger, Pres & CEO
- Ms. Mary-Jane E. Burkett CPA-CA, HBA, VP & CFO
- Ms. Katina K. Loucaides M.Sc., LL.B, VP, Corp. Sec. & Gen. Counsel
- Mr. Calogero Lunetta MSc, VP of Manufacturing
How do I buy shares of Nuvo Pharmaceuticals?
Shares of NRIFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Nuvo Pharmaceuticals' stock price today?
One share of NRIFF stock can currently be purchased for approximately $0.38.
How big of a company is Nuvo Pharmaceuticals?
What is Nuvo Pharmaceuticals' official website?
How can I contact Nuvo Pharmaceuticals?
Nuvo Pharmaceuticals' mailing address is 6733 MISSISSAUGA ROAD SUIT 610, MISSISSAUGA A6, L5N 6J5. The company can be reached via phone at 905-673-6980 or via email at [email protected]
MarketBeat Community Rating for Nuvo Pharmaceuticals (OTCMKTS NRIFF)
MarketBeat's community ratings are surveys of what our community members think about Nuvo Pharmaceuticals and other stocks. Vote "Outperform" if you believe NRIFF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NRIFF will underperform the S&P 500 over the long term. You may vote once every thirty days.
